SREBF1 and breast cancer: A commonly reported feature of endocrine therapy-resistant BC cell line models compared to isogenic sensitive lines is sterol regulatory element-binding protein 1 (SREBP)-driven upregulation of genes involved in lipid (notably cholesterol) biosynthesis, and targeting of SREBP was effective in reducing the growth of these resistant cell lines (67, 68).